Insider Shareholders with Direct Ownership of Blueprint Medicines Corp (BPMC)
This section provides a comprehensive overview of the insiders with direct ownership of Blueprint Medicines Corp (BPMC). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Blueprint Medicines Corp Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
| 478,415 | 467,453 | 152,396 $17.5 Million | 75 |
Jan 21, 2025
Reduced 0.13%
|
|
|
Kate Haviland
CHIEF EXECUTIVE OFFICER |
151,905 | 45,365 | 149,378 $17.2 Million | 24 |
Jan 21, 2025
Reduced 0.96%
|
| 9,692 | 0 | 74,160 $8.52 Million | 4 |
Jun 12, 2024
Added 2.93%
|
|
|
Fouad Namouni
PRESIDENT, R & D |
90,562 | 21,492 | 69,070 $7.94 Million | 12 |
Oct 03, 2024
Reduced 5.0%
|
|
Michael Landsittel
CHIEF FINANCIAL OFFICER |
98,743 | 48,885 | 67,208 $7.72 Million | 18 |
Aug 15, 2024
Reduced 6.16%
|
|
Christina Rossi
CHIEF OPERATING OFFICER |
67,687 | 20,943 | 67,109 $7.71 Million | 16 |
Jan 21, 2025
Reduced 0.18%
|
|
Tracey L Mc Cain
EVP AND CHIEF LEGAL OFFICER |
85,562 | 48,123 | 60,498 $6.95 Million | 15 |
Mar 07, 2024
Reduced 7.91%
|
| 20,601 | 9,815 | 58,026 $6.67 Million | 6 |
Jun 12, 2024
Added 3.72%
|
|
|
Percy H. Carter
CHIEF SCIENTIFIC OFFICER |
63,093 | 13,698 | 49,395 $5.68 Million | 11 |
Jul 01, 2024
Added 13.18%
|
|
Debra Durso Bumpus
CHIEF PEOPLE OFFICER |
135,069 | 110,541 | 43,763 $5.03 Million | 23 |
Jul 05, 2024
Reduced 8.09%
|
|
Philina Lee
CHIEF COMMERCIAL OFFICER |
68,921 | 54,546 | 34,729 $3.99 Million | 9 |
Aug 05, 2024
Reduced 54.69%
|
|
Christopher K. Murray
CHIEF TECHNICAL OPERATIONS |
44,000 | 23,995 | 33,853 $3.89 Million | 18 |
Mar 07, 2024
Reduced 6.93%
|
|
L. Becker Hewes
CHIEF MEDICAL OFFICER |
82,436 | 70,422 | 29,514 $3.39 Million | 24 |
Jun 04, 2024
Reduced 7.59%
|
|
Anthony L. Boral
Chief Medical Officer |
19,183 | 10,000 | 28,147 $3.23 Million | 3 |
Dec 14, 2020
Reduced 0.76%
|
| 47,419 | 32,727 | 18,254 $2.1 Million | 17 |
Jun 12, 2024
Added 10.94%
|
|
|
Marion Dorsch
Chief Scientific Officer |
16,778 | 16,778 | 15,250 $1.75 Million | 6 |
Feb 22, 2021
Reduced 33.2%
|
|
Ariel Hurley
PRINCIPAL ACCOUNTING OFFICER |
44,745 | 41,082 | 14,967 $1.72 Million | 43 |
Jan 13, 2025
Reduced 13.07%
|
| 9,692 | 0 | 13,254 $1.52 Million | 4 |
Jun 12, 2024
Added 14.47%
|
|
| 7,442 | 0 | 10,842 $1.25 Million | 3 |
Jun 12, 2024
Added 17.14%
|
|
| 8,742 | 0 | 8,742 $1 Million | 3 |
Jun 12, 2024
Added 20.41%
|
|
| 8,742 | 0 | 8,742 $1 Million | 3 |
Jun 12, 2024
Added 20.41%
|
|
| 4,860 | 768 | 8,412 $966,622 | 5 |
Jun 21, 2022
Added 23.61%
|
|
|
Charles A Rowland Jr
Director |
23,159 | 20,909 | 5,812 $667,856 | 7 |
Jun 02, 2021
Added 27.91%
|
|
Tango Therapeutics, Inc.
Director |
3,400 | 0 | 3,400 $390,694 | 1 |
Dec 08, 2021
Added 50.0%
|
| 18,504 | 19,824 | 2,242 $257,628 | 7 |
Nov 21, 2024
Reduced 81.42%
|